Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics July 1, 2003
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism June 14, 2003
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features. March 1, 2003
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia February 1, 2003
Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man January 1, 2003
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers June 24, 2002
